Will Stone

Will Stone, an NPR science reporter specializing in psychedelics and therapy, dives into the revolutionary potential of MDMA-assisted therapy for PTSD. He discusses the upcoming FDA decision that could approve this treatment, which has shown promising results in clinical trials. However, serious allegations of misconduct threaten to complicate the approval process. Stone also highlights the benefits veterans have experienced during trials and addresses the ethical controversies surrounding these groundbreaking studies.